Stay updated on Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page.

Latest updates to the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice about a lapse in government funding with the NIH Clinical Center open, and a new revision tag (v3.4.1) replacing v3.4.0, appear on the page.SummaryDifference0.4%

- Check9 days agoChange DetectedAdded a glossary toggle and new metadata lines: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed older metadata labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoChange DetectedNon-core administrative content such as IPD sharing plans, study document references, and historical record details were removed from the page. Core trial information (title, status, design, endpoints, and eligibility) remains unchanged.SummaryDifference18%

- Check23 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no substantive changes to study details or page layout are evident.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter revision information updated to v3.3.3. References to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin vs Placebo in HF: Arrhythmic Events Clinical Trial page.